Clinical Trials Logo

Neuropathic Pain clinical trials

View clinical trials related to Neuropathic Pain.

Filter by:

NCT ID: NCT06452615 Not yet recruiting - Neuropathic Pain Clinical Trials

Extracorporeal Shock Wave Therapy on Neuropathic Pain Post Mastectomy

Start date: June 15, 2024
Phase: N/A
Study type: Interventional

PURPOSE: The main objective of the study is: to evaluate the therapeutic effect of ESWT on intercostobrachial neuralgia post-mastectomy. BACKGROUND: Intercostobrachial neuralgia post-mastectomy is thought to develop from surgical damage to the intercostobrachial nerve, this nerve is injured in 80-100 % of mastectomy patients who undergo axillary lymph nodes dissection. Pain that is localized in the axilla, medial upper arm, breast, and/or chest wall significantly affects the patient's mood, everyday activities, and social functioning, causing a heavy economic burden on healthcare systems. If poorly treated, patients may develop an immobilized arm, which can lead to severe lymphedema, frozen shoulder syndrome, and complex regional pain syndrome. HYPOTHESES: It will be hypothesized that: Shock wave therapy has no effect in improving intercostobrachial neuralgia post-mastectomy.

NCT ID: NCT06444919 Not yet recruiting - Neuropathic Pain Clinical Trials

Capsaicin in Digital Osteoarthritis Versus Control

CADOR
Start date: September 1, 2024
Phase: Phase 4
Study type: Interventional

The objective of this multicentric, randomized controlled double-blind clinical trial is to demonstrate the efficacy of transdermal application of capsaicin in patients with painful digital osteoarthritis with a neuropathic pain component. Participants will receive either a transdermal patch of capsaicin 179 mg (8%) or the control treatment (capsaicin 0.04%). Researchers will compare the intensity of pain in the fingers at day 60 in the capsaicin 8% group versus capsaicin 0.04% (control arm)

NCT ID: NCT06438471 Recruiting - Clinical trials for Spinal Cord Injuries

Novel Soluble Epoxide Hydrolase Inhibitor for Neuropathic Pain in Patients With Spinal Cord Injury

Start date: July 2024
Phase: Phase 1
Study type: Interventional

The goal of this clinical trial is to evaluate safety and tolerability of multiple oral doses of EC5026 in male and female patients with neuropathic pain due to spinal cord injury. The main question it aims to answer is whether EC5026 is safe and well tolerated in SCI patients with neuropathic pain. In addition, this trial will also study the effects of EC5026 on pain. Researchers will compare EC5026 to placebo. Participants will be asked to: - Take EC5026 or placebo in a masked fashion, once daily, for 14 consecutive days. - Undergo physical exams, vital signs assessments, ECGs, and blood draws - Complete assessments of pain, sleep, functional status, and perception of change

NCT ID: NCT06430918 Enrolling by invitation - Knee Osteoarthritis Clinical Trials

Neuropathic Pain and it's Relation to Sleep Quality in Knee Osteoarthritis

Start date: May 16, 2024
Phase:
Study type: Observational [Patient Registry]

The primary aim is to investigate the frequency and severity of neuropathic pain and its association with night pain in patients with knee osteoarthritis. For this purpose a progressive longitudinal study design was planned. The secondary aim is to investigate the relationship between night pain and neuropathic pain and sleep quality.

NCT ID: NCT06420141 Recruiting - Neuropathic Pain Clinical Trials

The Prevalence of Neuropathic Pain Pathophysiology Associated With Ankle Fracture

Start date: January 3, 2024
Phase:
Study type: Observational

This application addresses the Peer Reviewed Medical Research Program Investigator-Initiated Research Award FY21 W81XWH-22-CPMRP-IIRA area of Chronic Pain Management Research Program- The investigators will utilize subjects who have sustained ankle fractures and may develop chronic pain following bone union. No attempt will be made to affect the experimental outcome in the subjects. This study will adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of research.

NCT ID: NCT06414356 Not yet recruiting - PTSD Clinical Trials

The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD

Start date: May 2024
Phase: Phase 4
Study type: Interventional

This study is aimed to evaluate outpatient ketamine infusion within a military chronic neuropathic pain population and its effect on PTSD. Currently, this is a pilot study with 30 participants. Participants will be randomized to (1) a moderate dose ketamine, (2) moderate dose ketamine +Mg, or (3) a magnesium control group. Participants will complete self-reported pain and PTSD questionnaires throughout the ~24-week study period. The outlined strategy will provide evidence for the utility of ketamine in neuropathic pain management and pain associated comorbidities within a military population.

NCT ID: NCT06407167 Recruiting - Neuropathic Pain Clinical Trials

Neuropathic Pain in Patients With Degenerative Lumbar Stenosis

Start date: May 13, 2024
Phase:
Study type: Observational

Pre- and postoperative pain in patients with degenerative stenosis requires great attention, as it can mislead the doctor about treatment tactics. Neuropathic pain in the legs before and after the surgical procedure, as well as the residual or recurrent pain syndrome existing against this background, overshadow the patient's recovery and cast doubt on the fullness of the performed decompression. Neural compression in the spinal canal and back pain may be the cause of the patient's antalgic posture and sagittal imbalance as seen on X-Ray, to need for corrective interventions surgical procedure. Thus, it is necessary to clarify the role and the influence of the pain and its type on the perioperative period in patients with degenerative lumbar spinal stenosis.

NCT ID: NCT06398847 Not yet recruiting - Neuropathic Pain Clinical Trials

Virtual Reality (VR) Self-Hypnosis Software

Start date: May 2024
Phase: N/A
Study type: Interventional

This single-site study of self-hypnosis software using an off-the-shelf virtual reality (VR) device (OculusGoâ„¢) to determine the software's safety, usability, and preliminary efficacy in pain relief for HIV-associated chronic pain patients. This is funded under the i Prism Funding through Mount Sinai Innovations.

NCT ID: NCT06390150 Not yet recruiting - Pain, Postoperative Clinical Trials

Spinal Cord Stimulation Pioneering Analgesia for Resilient Recovery in Post Intra-Thoracic Surgery Pain

SPARK
Start date: June 2024
Phase: N/A
Study type: Interventional

This study aims to determine the effectiveness of spinal cord stimulation in patients with post intra-thoracic surgery pain syndrome in a placebo-controlled, crossover, randomized clinical trial.

NCT ID: NCT06367998 Not yet recruiting - Neuropathic Pain Clinical Trials

Effect of Pregabalin on Shoulder Pain in Patients With Central Sensitization After Arthroscopic Rotator Cuff Repair

Start date: May 1, 2024
Phase: Phase 4
Study type: Interventional

This study aims to investigate the effects of Pregabalin intake on shoulder pain management in patients with central sensitization undergoing arthroscopic rotator cuff repair. Although Pregabalin is known to be effective in controlling pain after shoulder arthroscopy, research on its efficacy in pain management for patients with central sensitization is scarce. Utilizing a list that identifies central sensitization, this study will explore whether Pregabalin can reduce postoperative pain in these patients and potentially improve joint mobility, emotional, and physical functioning. A prospective randomized study is planned, with inclusion criteria set for patients aged between 19 and 70 who have undergone arthroscopic rotator cuff repair. The study will compare clinical outcomes up to one year postoperatively between two groups of 38 patients each. The case group will receive standard postoperative medications (NSAIDs) plus Pregabalin oral intake from the day before surgery to six weeks postoperatively, while the control group will receive only the standard postoperative medications without Pregabalin.